Peritoneal inflammation – A microenvironment for Epithelial Ovarian Cancer (EOC)

Peritoneal inflammation – A microenvironment for Epithelial Ovarian Cancer (EOC)

<p>Abstract</p> <p>Epithelial ovarian cancer (EOC) is a significant cause of cancer related morbidity and mortality in women. Preferential involvement of peritoneal structures contributes to the overall poor outcome in EOC patients. Advances in biotechnology, such as cDNA microarra...

Full description

Bibliographic Details
Main Authors:	Liu Jinsong, Deavers Michael, Freedman Ralph S, Wang Ena
Format:	Article
Language:	English
Published:	BMC 2004-06-01
Series:	Journal of Translational Medicine
Online Access:	http://www.translational-medicine.com/content/2/1/23

Similar Items

Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.
by: Ganna Chornokur, et al.
Published: (2015-01-01)

Invasive epithelial ovarian carcinoma (EOC) at a young age: role of fertility-sparing
by: Puja Agung Antonius, et al.
Published: (2022-05-01)

Ovarian cancer, the coagulation pathway, and inflammation
by: Kavanagh John J, et al.
Published: (2005-06-01)

FPR2 participates in epithelial ovarian cancer (EOC) progression through RhoA-mediated M2 macrophage polarization
by: Xiaohui Xie, et al.
Published: (2021-12-01)

SOS1 promotes epithelial-mesenchymal transition of Epithelial Ovarian Cancer(EOC) cells through AKT independent NF-κB signaling pathway
by: Min Cheng, et al.
Published: (2021-09-01)

Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway
by: Yong-Bin Liu, et al.
Published: (2018-04-01)

Tumor microenvironment in ovarian cancer peritoneal metastasis
by: Shuangshuang Mei, et al.
Published: (2023-01-01)

Principles of emergency management and emergency operations centers (EOC) /
by: Fagel, Michael J.
Published: (2011)

El primer recuerdo de la EOC
by: Fernando Méndez-Leite
Published: (2016-06-01)

Response to neoadjuvant chemotherapy in ICON8: A GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment
by: Clamp, A, et al.
Published: (2018)

Host Mesothelin Expression Increases Ovarian Cancer Metastasis in the Peritoneal Microenvironment
by: Tyvette S. Hilliard, et al.
Published: (2021-11-01)

Lysophospholipid Signaling in the Epithelial Ovarian Cancer Tumor Microenvironment
by: Yan Xu
Published: (2018-07-01)

ICON8: A GCIG phase III randomised trial evaluating weekly dosedense chemotherapy integration in first- line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: Results of primary progression- free survival (PFS) analysis
by: Clamp, A, et al.
Published: (2017)

EOC: Energy Optimization Coding for Wireless Nanosensor Networks in the Terahertz Band
by: Long-Jun Huang, et al.
Published: (2017-01-01)

LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model
by: Sadia Mehdi, et al.
Published: (2020-07-01)

Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation
by: Dai Lan, et al.
Published: (2022-01-01)

Pretreatment CT differential diagnosis of tuberculous peritonitis from peritoneal carcinomatosis of advanced epithelial ovarian cancer
by: Chul-min Lee, et al.
Published: (2023-01-01)

The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy
by: Galaxia M. Rodriguez, et al.
Published: (2018-07-01)

Obesity modulates the cellular and molecular microenvironment in the peritoneal cavity: implication for ovarian cancer risk
by: Amanda A. Shea, et al.
Published: (2024-01-01)

Modification of the Tumor Microenvironment in KRAS or c-MYC-Induced Ovarian Cancer-Associated Peritonitis.
by: Mitsuyo Yoshida, et al.
Published: (2016-01-01)

Early stage epithelial ovarian cancer metastasis through peritoneal fluid circulation
by: Sigit Purbadi, et al.
Published: (2021-03-01)

Preparation of visible light-responsive catalyst for emerging organic contaminants (EOCs) degradation
by: Leao, Li Wei
Published: (2014)

Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma
by: Garcia Michael E, et al.
Published: (2007-12-01)

With Great Age Comes Great Metastatic Ability: Ovarian Cancer and the Appeal of the Aging Peritoneal Microenvironment
by: Elizabeth I. Harper, et al.
Published: (2018-07-01)

P12.12 The tumor microenvironment of epithelial ovarian cancer: exhausted and immunosuppressive
by: F Trillsch, et al.
Published: (2024-03-01)

Fluid-flow induced wall shear stress and epithelial ovarian cancer peritoneal spreading.
by: Liron Avraham-Chakim, et al.
Published: (2013-01-01)

Editorial: Molecular physiopathology of epithelial ovarian cancer: role of inflammation
by: Gitana Maria Aceto, et al.
Published: (2024-01-01)

EPON-EoC的拓扑自动发现研究与实现
by: 尹恒, et al.
Published: (2015-01-01)

La conservación y las prácticas del IIEC y de la EOC
by: Lourdes Odriozola Cuevas
Published: (2016-06-01)

The Stress-Inducible BCL2A1 Is Required for Ovarian Cancer Metastatic Progression in the Peritoneal Microenvironment
by: Rui Liang, et al.
Published: (2021-09-01)

Characterization of tumour microenvironment reprogramming reveals invasion in epithelial ovarian carcinoma
by: Yuanfu Zhang, et al.
Published: (2023-10-01)

Shifting the Soil: Metformin Treatment Decreases the Protumorigenic Tumor Microenvironment in Epithelial Ovarian Cancer
by: Sarah E. Taylor, et al.
Published: (2022-05-01)

Second primary cancer after primary peritoneal, epithelial ovarian, and fallopian tubal cancer: a retrospective study
by: Myong Cheol Lim, et al.
Published: (2018-08-01)

Characteristics of the receptor phenotype of tumor-associated immune cells of the epithelial-mesenchymal microenvironment of ovarian cancer
by: Varvara N. Zhurman
Published: (2023-05-01)

Cancer-Associated Fibroblasts and Their Putative Role in Potentiating the Initiation and Development of Epithelial Ovarian Cancer
by: Isaiah G. Schauer, et al.
Published: (2011-05-01)

The Effects of Divalent Cation-Chelated Prion Fibrils on the Immune Response of EOC 13.31 Microglia Cells
by: Huan-I Jen, et al.
Published: (2020-10-01)

The Endometriotic Tumor Microenvironment in Ovarian Cancer
by: Jillian R. Hufgard Wendel, et al.
Published: (2018-08-01)

CD38 Predicts Favorable Prognosis by Enhancing Immune Infiltration and Antitumor Immunity in the Epithelial Ovarian Cancer Microenvironment
by: Ying Zhu, et al.
Published: (2020-04-01)

Use of Transabdominal Ultrasound for the detection of intra-peritoneal tumor engraftment and growth in mouse xenografts of epithelial ovarian cancer.
by: Laura M Chambers, et al.
Published: (2020-01-01)

Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients
by: Karolina Okła, et al.
Published: (2018-10-01)